Literature DB >> 10732754

Desmoids in familial adenomatous polyposis are monoclonal proliferations.

S B Middleton1, I M Frayling, R K Phillips.   

Abstract

Desmoids are poorly-understood, locally aggressive, non-metastasizing fibromatoses that occur with disproportionate frequency in patients with familial adenomatous polyposis (FAP). Their nature is controversial with arguments for and against a neoplastic origin. Neoplastic proliferations are by definition monoclonal, whereas reactive processes originate from a polyclonal background. We examined clonality of 25 samples of desmoid tissue from 11 female FAP patients by assessing patterns of X-chromosome inactivation to calculate a clonality ratio. Polymerase chain reaction (PCR) amplification of a polymorphic CAG short tandem repeat (STR) sequence adjacent to a methylation-sensitive restriction enzyme site within the human androgen receptor (HUMARA) gene using fluorescent-labelled primers enabled analysis of PCR products by Applied Biosystems Genescan II software. Twenty-one samples from nine patients were informative for the assay. Samples from all informative cases comprised a median of 66% (range 0-75%) clonal cells but from the six patients with a clonality ratio < or =0.5 comprised a median of 71% (65-75%) clonal cells. FAP-associated desmoid tumours are true neoplasms. This may have implications in the development of improved treatment protocols for patients with these aggressive tumours.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10732754      PMCID: PMC2374411          DOI: 10.1054/bjoc.1999.1007

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  42 in total

1.  Some desmoid tumors are characterized by trisomy 8.

Authors:  P Dal Cin; R Sciot; M S Aly; J Delabie; M Stas; I De Wever; B Van Damme; H Van den Berghe
Journal:  Genes Chromosomes Cancer       Date:  1994-06       Impact factor: 5.006

2.  Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis.

Authors:  K P Nugent; A D Spigelman; R K Phillips
Journal:  Dis Colon Rectum       Date:  1993-11       Impact factor: 4.585

3.  Trisomy 20 characterizes a second group of desmoid tumors.

Authors:  P Dal Cin; R Sciot; B Van Damme; I De Wever; H Van den Berghe
Journal:  Cancer Genet Cytogenet       Date:  1995-02

4.  PCR bias in amplification of androgen receptor alleles, a trinucleotide repeat marker used in clonality studies.

Authors:  G L Mutter; K A Boynton
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

Review 5.  Chemotherapy for desmoid tumours in association with familial adenomatous polyposis: a report of three cases.

Authors:  L Hamilton; M Blackstein; T Berk; R S McLeod; S Gallinger; L Madlensky; Z Cohen
Journal:  Can J Surg       Date:  1996-06       Impact factor: 2.089

6.  Desmoid tumours in familial adenomatous polyposis.

Authors:  A K Gurbuz; F M Giardiello; G M Petersen; A J Krush; G J Offerhaus; S V Booker; M C Kerr; S R Hamilton
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

7.  Quantitative non-radioactive clonality analysis of human leukemic cells and progenitors using the human androgen receptor (AR) gene.

Authors:  E Delabesse; S Aral; P Kamoun; B Varet; A G Turhan
Journal:  Leukemia       Date:  1995-09       Impact factor: 11.528

8.  Desmoid tumors in patients with familial adenomatous polyposis.

Authors:  M A Rodriguez-Bigas; M C Mahoney; C P Karakousis; N J Petrelli
Journal:  Cancer       Date:  1994-08-15       Impact factor: 6.860

Review 9.  Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner's syndrome.

Authors:  H T Lynch; R Fitzgibbons; S Chong; J Cavalieri; J Lynch; F Wallace; S Patel
Journal:  Dis Colon Rectum       Date:  1994-03       Impact factor: 4.585

Review 10.  The multistep nature of cancer.

Authors:  B Vogelstein; K W Kinzler
Journal:  Trends Genet       Date:  1993-04       Impact factor: 11.639

View more
  9 in total

Review 1.  Current ideas in desmoid tumours.

Authors:  N Julian H Sturt; Susan K Clark
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

Review 2.  Mesenteric fibromatosis.

Authors:  Poras Chaudhary
Journal:  Int J Colorectal Dis       Date:  2014-08-21       Impact factor: 2.571

3.  Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors.

Authors:  Adelaide M Carothers; Hira Rizvi; Rian M Hasson; Yvonne I Heit; Jennifer S Davids; Monica M Bertagnolli; Nancy L Cho
Journal:  Cancer Res       Date:  2011-11-17       Impact factor: 12.701

4.  The identification of monoclonality in fibrous dysplasia by methylation-specific polymerase chain reaction for the human androgen receptor gene.

Authors:  Masae Mikami; Hirotaka Koizumi; Masamitsu Ishii; Hisaya Nakajima
Journal:  Virchows Arch       Date:  2003-10-24       Impact factor: 4.064

Review 5.  Desmoid tumour in familial adenomatous polyposis. A review of literature.

Authors:  A L Knudsen; S Bülow
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

6.  Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma.

Authors:  Ole William Petersen; Helga Lind Nielsen; Thorarinn Gudjonsson; René Villadsen; Fritz Rank; Erik Niebuhr; Mina J Bissell; Lone Rønnov-Jessen
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

7.  Extra-abdominal desmoid tumors associated with familial adenomatous polyposis.

Authors:  George T Calvert; Michael J Monument; Randall W Burt; Kevin B Jones; R Lor Randall
Journal:  Sarcoma       Date:  2012-06-03

8.  Clonal analysis of palmar fibromatosis: a study whether palmar fibromatosis is a real tumor.

Authors:  Lei Wang; Hongguang Zhu
Journal:  J Transl Med       Date:  2006-05-12       Impact factor: 5.531

9.  Determination of stromal signatures in breast carcinoma.

Authors:  Robert B West; Dimitry S A Nuyten; Subbaya Subramanian; Torsten O Nielsen; Christopher L Corless; Brian P Rubin; Kelli Montgomery; Shirley Zhu; Rajiv Patel; Tina Hernandez-Boussard; John R Goldblum; Patrick O Brown; Marc van de Vijver; Matt van de Rijn
Journal:  PLoS Biol       Date:  2005-05-10       Impact factor: 8.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.